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Background: Fallopian tube secretory epithelial cells (FTSECs) have been implicated as a cell-of-origin for high-
grade serous epithelial ovarian cancer. However, there are relatively few in vitro models of this tissue type available
for use in studies of FTSEC biology and malignant transformation. In vitro three-dimensional (3D) cell culture models
aim to recreate the architecture and geometry of tissues in vivo and restore the complex network of cell-cell/cell-
matrix interactions that occur throughout the surface of the cell membrane.
Results: We have established and characterized 3D spheroid culture models of primary FTSECs. FTSEC spheroids
contain central cores of hyaline matrix surrounded by mono- or multi-layer epithelial sheets. We found that 3D
culturing alters the molecular characteristics of FTSECs compared to 2D cultures of the same cells. Gene expression
profiling identified more than a thousand differentially expressed genes between 3D and 2D cultures of the same
FTSEC lines. Pathways significantly under-represented in 3D FTSEC cultures were associated with cell cycle
progression and DNA replication. This was also reflected in the reduced proliferative indices observed in 3D
spheroids stained for the proliferation marker MIB1. Comparisons with gene expression profiles of fresh fallopian
tube tissues revealed that 2D FTSEC cultures clustered with follicular phase tubal epithelium, whereas 3D FTSEC
cultures clustered with luteal phase samples.
Conclusions: This 3D model of fallopian tube secretory epithelial cells will advance our ability to study the
underlying biology and etiology of fallopian tube tissues and the pathogenesis of high-grade serous epithelial
ovarian cancer.
Keywords: Fallopian tube secretory epithelial cells, Gene expression microarray, Three-dimensional in vitro models,
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The human fallopian tube is lined by a simple columnar
epithelium consisting of both ciliated and secretory
epithelial cells. Fallopian tube secretory epithelial cells
(FTSECs) are of particular interest given their proposed
role as a precursor tissue for high-grade serous epithelial
ovarian cancers, which is the most common ovarian can-
cer histological subtype [1,2]. However, the biology of
FTSECs remains poorly understood. This is partly due
to difficulties in accessing normal primary FTSECs and
in the subsequent development of in vitro models of this* Correspondence: gayther@usc.edu
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distribution, and reproduction in any mediumtissue type. Primary FTSECs have proved challenging to
culture, reportedly loosing expression of differentiated
markers when propagated in vitro. This indicates a cellu-
lar plasticity that is strongly influenced by culture condi-
tions [3]. Recent advances in ex vivo culture of fallopian
epithelia have been achieved by plating the cells onto
collagen matrices [4,5]. Under these conditions lineage
and differentiation markers are maintained, but unfortu-
nately the cells have an limited capacity for proliferation
and cannot be sub-cultured without being immortalized
or transformed [6].
Current evidence suggests that FTSECs are a likely
origin of high-grade serous epithelial ovarian cancers
(HGSOCs) [1,2]. The biological characteristics of the cell-
of -origin for different cancers are likely to influence
the etiology of the malignant disease [7], including thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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opment. Gaining a better understanding of the initiation
and early stage development of HGSOCs is likely to be of
clinical importance. The majority of epithelial ovarian tu-
mors are diagnosed at the late stages (stage III/IV) when
5-year survival rates are only ~30%. In contrast, patients
diagnosed with stage I disease have survival rates of over
90%, and are often cured by surgical intervention. The
ability to detect HGSOCs in the earliest stages would rep-
resent a realistic approach to reducing mortality and a bet-
ter understanding of the role of FTSECs in the initiation
of HGSOCs may be key to the discovery of novel bio-
markers associated with early stage disease.
Although the basic functions of all epithelia are the
same, there are many fundamental differences in cell
morphology, cell function and gene expression across
the epithelial cells of different organs. Regardless of cell
type, classical cell culture techniques typically involve
culturing cells on plastic surfaces that bear limited re-
semblance to the organs from which the cells originate.
Traditional two-dimensional (2D) in vitro techniques
loose the architecture and geometrical features of tissues
in vivo, as well as the gradients of nutrients, oxygen, car-
bon dioxide and other factors that characterize these
tissues. Seminal work in three-dimensional (3D) model-
ing by Bissell and colleagues has shown that culturing
normal breast epithelial cells in 3D can induce gland for-
mation, restore cellular polarity and induce upregulated
expression of biologically active molecules, thereby
simulating the in vivo environment [8-10]. Similar ap-
proaches have since been used for other epithelial cell
types. In most instances, 3D cultures display histological
features and differentiated phenotypes that are rarely
achieved in 2D cultures [10-12]. The aim of the current
study was to establish new 3D models of FTSECs, andTable 1 Patient information
Cell line Patient age Menopausal status Clinical data
FTE01 51 NK Mucinous cyst on the
left ovary
FTE02 50 NK Benign fibrosis Le
FTE03 38 Pre Fibroid. Adenomyosis Sec
FTE05 54 Post Complex hyperplasia
with atypia No
FTE283 65 Post Grade 2–3 endometrial
cancer aden
w
FTE284 60 Post History proven
endometrial cancer
Grad
FTSEC cell lines were collected from patients aged between 38 and 65 years of age
normal. For the pre-menopausal patient the phase of the menstrual cycle was not kto investigate whether 3D FTSEC cultures are more
biologically relevant models than monolayer cultures.
We developed in vitro 3D cultures of FTSECs that
mimic features of fallopian tube epithelia in vivo; the
characteristics of these models suggests that they are
suitable for studying both the biology of normal fallopian
tube epithelial cells and the early-stage development of
HGSOCs.
Results
Isolation of fallopian tube secretory epithelial cells
Fallopian tube epithelial cells were isolated from disease-
free fallopian tubes of women undergoing partial salpin-
gectomy or total abdominal hysterectomy with bilateral
salpingoophorectomy (Table 1). Epithelial cells were
harvested from the ampullary regions of fallopian tube
samples. Primary cell cultures were confirmed as epithe-
lial by immunofluorescent staining to analyze expression
of cytokeratin (Figure 1a). Two of five FTSEC cultures also
expressed the gynecological epithelial cell marker CA125.
The absence of stromal contaminants was shown by ab-
sence of staining for Von Willenbrand Factor VIII, which
is expressed by endothelial cells, and the fibroblastic
marker fibroblast surface protein (data not shown).
Almost all cells in FTSEC cultures expressed the lineage-
specific marker PAX8 in the nucleus (Figure 1a), indicat-
ing that the cell culture protocol enriched for fallopian
tube secretory epithelial cells (FTSECs) [1,13]. FTSECs
also expressed vimentin and laminin (Figure 1a). FTSECs
could be successfully subcultured but had a limited life-
span in culture, which is typical of primary cells. Primary
FTSECs proliferated for 34–60 days (equating to 10–16
passages in culture) (Figure 1b) at which point cells ac-
quired senescent morphologies and expressed senescence-
associated β-galactosidase (data not shown). The modalHistopathological diagnosis Histopathology report – ovaries
and fallopian tubes
Benign follicular and epithelial
inclusion cysts. Benign serous
cystadenofibroma.
Fallopian tubes normal
iomyomas and folicular ovarian
cysts
Mild chronic salpingitis in one tube
but no evidence of malignancy




evidence of invasive carcinoma.
Benign leiomyomas.
Post-menopausal features present in
both ovaries. Fallopian tubes normal.
Grade 2 endometrioid
ocarcinoma of the endometrium,
ith >50% myometrial invasion
Post-menopausal features present in
both ovaries. Fallopian tubes normal.
e 2 endometrioid adenocarcinoma
of the endometrium
Fallopian tubes normal
. For all patients, fallopian tube tissues were confirmed to be histologically
nown. NK = not known.
Figure 1 Characterization of primary FTSEC in vitro cultures. (a) Primary FTSEC cultures maintain expression of markers expressed by
fallopian tube secretory epithelia in vivo (arrowheads indicate secretory, non-ciliated cells), the FTSEC cultures express cytokeratins, CA125, basal
laminin, vimentin and nuclear PAX8. 90-100% of cells stain positive for PAX8 suggesting fallopian tube ciliated epithelial cells do not proliferate
in vitro. Green stain shows positive staining, nuclei are counterstained with DAPI (blue), except in the case of PAX8. (b) Growth curves. FTSECs
have a limited in vitro lifespan, as is typical for primary normal cells. (c) Modal karyotypes for 5/6 primary FTSEC cultures were normal and female
(46,XX). # Two cells or fewer showed unbalanced structural chromosomal rearrangements or numerical abnormalities.
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line (FTSEC05) displayed an abnormal karyotype of 46,
XX, t(6;6) (p21;q21) in all of the 19 cells analyzed, and was
therefore excluded from further analyses.
Three-dimensional culturing of FTSECs
Three-dimensional (3D) cultures of FTSECs were estab-
lished by inoculating cells into polyHEMA-coated tissue
culture plastics as previously described for normal and
transformed ovarian epithelial cells [14-16]. Within
24 hours of culture, FTSECs aggregated and spontan-
eously formed multicellular spheroids. After 14 days,
FTSEC spheroids were fixed, paraffin-embedded and
sectioned, and the histological features examined by
hematoxylin and eosin (H&E) staining. All five primary
lines grew as spheroids and revealed a similar cellular
architecture. A monolayer of epithelial-like cells typically
surrounded each spheroid and in some instances there
was also multi-layering of the epithelium. FTSEC spher-
oids commonly displayed a crescent-shaped cellular cap
structure, which we have previously described for pri-
mary normal ovarian epithelial cell cultures in 3D [14].
The centre of the spheroids comprised a hyaline matrixthat resembled the extracellular matrix present in the
in vivo tissue in composition (Figures 2 and 3). We ob-
served some viable cells amongst abundant karyorrhectic
debri (nuclear dust) within the matrix core of the spher-
oids. Many of the viable cells within spheroid cores (but
not cells on the periphery) exhibited nuclear and cellular
pleomorphism, suggesting these cells undergo apoptosis
and degenerate (Figure 2a (ii)). In doing so, these cells
contribute to the matrix material that makes up the struc-
ture of the core of FTSEC spheroids. The internal struc-
ture and sub-cellular features of three-dimensional
spheroid cultures of FTSECs, examined by transmission
electron microscopy revealed features of epithelial cells, in-
cluding microvilli (Figure 2b (i)), tight junctions (Figure 2b
(ii & iii)) and adherens junctions (Figure 2b (iv)).
We compared molecular features between 2D and 3D
FTSEC cultures using immunohistochemistry for series
of biomarkers either known to be expressed in normal
fallopian tube epithelia or relevant to the biology of FTSECs
in serous carcinogenesis (Figure 3, Table 2). FTSECS are
not highly proliferative in vivo, but have high proliferative
indices when cultured as a monolayer (Figure 1b and
Figure 3). MIB1, which is expressed during G1, S, G2 and
Figure 2 Histological analysis of 3D FTSEC spheroids. (a) Three dimensional spheroid cultures stained by hematoxylin and eosin. At
(i) 15 days, the core of the spheroids contains abundant matrix material (*), covered by an epithelial cell monolayer (arrow) or cellular cap
structure (arrowhead). (ii) After 40 days no viable cells remain within the core of the spheroids. A viable monolayer covers the surface of the
spheroid (arrow), degenerate nuclear debris can be seen within the matrix core (arrowhead). (b) Electron microscopy of FTSEC spheroids.
Features of epithelial cells in vivo are detected in 3D cultured FTSECs including (i) microvilli and cell-cell junction complexes including (ii,iii) tight
junctions (white arrows and inset) and (iv) adherens junctions (white arrows and inset). Electron microscopy.
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the G2/M cell cycle checkpoint both showed marked re-
ductions in expression in 3D cultured FTSECs compared
to 2D cultures, suggesting that FTSECs are less proliferative
in 3D compared to 2D (Figure 3 and Table 2). This is con-
sistent with the expression of these markers in vivo. PAX8
and E-Cadherin showed no reproducible changes in expres-
sion in 2D compared to 3D cultures. Vimentin showed
higher expression in 2D cultured cells and in primary tis-
sue, but showed a modest reduction in expression in 3D
for all cell lines examined. The basement membrane pro-
tein laminin was expressed at high levels in both 2D and
3D cultures. Fibronectin and collagen I were expressed at
high levels by epithelial cells of the fallopian tube; these
markers were expressed at low levels in 2D FTSEC cultures
and were then upregulated in 3D. Collagen IV expression
was restricted to the basal lamina and stroma of human fal-
lopian tube tissues but was ectopically expressed at high
levels in 2D cultures and then reduced in 3D cultures,
which is more reflective of human tissues. One cell line
(FTE283) showed increased expression of mucins (mucin 1and mucin 16, also known as CA125) in 3D cultures, but
for the other cell lines these mucins were either expressed
at low levels (in 2D cultures) or not all (in 3D cultures).
Whole transcriptome analyses of FTSECs
We profiled the genes and pathways differentially ex-
pressed when FTSECs transition from a 2D to 3D
microenvironment. Three FTSEC lines were cultured as
2D monolayers and 3D spheroids for 4 days and whole
transcriptome profiling performed using the Illumina
HT12 beadchip microarrays. In total, 1005 probes were
differentially expressed between 2D and 3D cultures
(SAM analysis, FDR = 5.80×10-5, two-class unpaired test,
δ = 5.16). Figure 4 shows a heatmap of the top 100 sig-
nificantly changing genes between 2D and 3D cultures
(also listed in Additional file 1: Table S1). Among the
most significantly down-regulated genes were those cod-
ing for membrane proteins (MARCH4, fold change (FC)
0.065; TMEM106C, FC = 0.22), DNA repair proteins
(RAD51C, represented by 2 probes showing fold changes
of 0.44 and 0.46) and Rho signaling proteins (DIAPH3,
Figure 3 Immunohistochemical staining of 2D and 3D cultured FTSECs and primary fallopian tube tissue. Immunohistochemical staining
of p53 (clone Do7) and a proliferation marker, MIB1, shows high expression of both markers in 2D cultured cells but low expression in 3D FTSEC
cultures (at day 15), and fallopian tube epithelia in vivo. Laminin and vimentin are expressed in 2D cultured cells, 3D cultured cells and in vivo.
Expression of fibronectin and collagen I was lower in 2D cultured cells than 3D cultures and fallopian tube epithelia in fresh tissue specimens.
Collagen IV is predominantly expressed in the basal lamina (arrow) and stroma of fallopian tubes but was expressed at high levels by 2D cultured
cells. Expression of this marker was low/absent in 3D cultured cells. * Fibronectin, collagen I and collagen IV were also examined in FTSEC01,
expression patterns were highly similar to data for FTSEC283 and FTSEC03. Expression of collagen IV was restricted to the basal lamina and
stroma. None of the markers examined were differentially expressed by ciliated and secretory fallopian tube epithelial cells in vivo. As our cell
isolates were predominantly PAX8 positive (Figure 1), we do not expect ciliated cells to be present in the FTSEC spheroid cultures. Brown stain
denotes positive antigen detection, cells are counterstained with eosin (blue). Light microscopy. Scale bars = 100 μm.
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Table 2 Summary of immunohistochemical staining of FTSEC spheroids
FTE02 FTE03 FTE283 FTE284 TISSUE
Marker 2D 3D 2D 3D 2D 3D 2D 3D FTE03 FTE04
AE1:AE3 ++ +/− +++ + +++ ++++ ++++ ++ ++++ ++++
VIMENTIN +++ ++ ++++ +++ ++++ +++ ++++ +++ ++++ +++
LAMININ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++ ++
MUC-1 ++ +/− + - + +++ ++ - ++++ +++
CA125 + - + - +/− ++ ++ - +++ +++
PAX8 + - ++ +/− +++ +++ ++ +/− +++ ++
TP53 (Do7) +++ +/− +++ + ++ + +++ +/− + +/−
MIB-1 (%) 70% <5% 70% <5% 70% <5% 50% <5% <5% <5%
Immunohistochemistry was performed on five FTSEC cultures grown as 2D monolayers and as 3D spheroids, and compared to two fresh tissue specimens.
Staining of pan-cytokeratin (AE1:AE3), mucin-1, CA125, PAX8 and E-Cadherin showed no significant changes in 2D versus 3D cultured cells. Laminin showed high
levels of expression in all samples and expression along the basement membrane of fallopian tube epithelial cells in vivo. TP53 and MIB1 expression were high in
2D cultured cells, but low in 3D cultured cells and in vivo.
Figure 4 Gene expression microarray analysis of 2D and 3D cultured FTSECs. Hierarchical clustering of transcriptomic profiles of the 100
genes showing the most significant changes in expression between three 2D and 3D cultured FTSEC primary lines. Three independent samples
were prepared for each cell line and each culture condition, each sample represents an individual microarray, technical replicates are shown. Cell
lines cluster according to culture conditions, not patient.
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up-regulated in 3D cultured cells included those coding
for ATP-binding cassette transporters (ABCC3, FC =
4.19; ABCA2, FC = 3.24) and trans-membrane proteins
(TMTC1, FC = 1.97; TMCO3, FC = 2.05; TMEM117,
FC = 2.19) (Table 3). Hierarchical clustering of Elucidean
distances between samples showed that the differences
were greater between 2D and 3D culture conditions
than for FTSECs from different patients (Figure 4). The
three most significantly up- and down-regulated genes
were validated by qPCR (Additional file 2: Figure S1 and
Figure 5). MARCH4 and DIAPH3 were significantly
downregulated in 3D cultured cells compared to 2D
cultures (P > 0.05, Figure 5a,b). GINS4 showed a similar
trend although changes in expression in 2D versus 3D
were not statistically significant (Figure 5c). C11orf96,
OLFM2A and LRRK2 were consistently overexpressed in
3D cultured cells compared to the same cells cultured in
2D (Figure 5d-f, P > 0.05).
We performed gene ontology (GO) analyses using the
top 1005 probes representing 821 unique Entrez identi-
fiers. For a sub-set of 354 identifiers that were signifi-
cantly downregulated in 3D cultures, 80 GO terms wereFigure 5 Validation of genes identified through expression microarra
changing genes were validated by TaqMan qPCR in independent 2D and 3
different patients (FTSEC01 and FTSEC284). Genes downregulated in 3D cu
downregulated in all 3 cell lines tested with the exception. (c) A similar tre
significance. Genes upregulated in 3D cultured cells (d) C11orf96, (e) OLFM
transition to a 3D microenvironment. * P > 0.05, ** P > 0.01, *** P > 0.001, tw
cultured cells for each cell line individually.significantly over-represented; 75% of these were associ-
ated with cell division, mitosis, telomere maintenance,
DNA replication and repair (Table 3). The most signifi-
cantly over-represented term was organelle fission (P =
2.00×10-25). Positive regulation of transcription from RNA
polymerase II promotor was the only GO term signifi-
cantly over-represented in the 467 identifiers that were
overexpressed in 3D cultures (Table 3), which is likely to
reflect the widespread changes in gene expression ob-
served when FTSECs transition from a 2D to 3D micro-
environment. No GO terms were found to be under-
represented in the 1005 probes that significantly different
in the comparison of 2D and 3D FTSEC cultures.
We took two approaches to examine whether 3D cultur-
ing of FTSECs affects functional differentiation. Firstly we
examined expression of genes that encode proteins known
to be secreted by FTSECs in vivo: oviduct specific glyco-
protein 1 (OVGP1), pregnancy-associated plasma protein
A (PAPPA) and tissue factor pathway inhibitor 2 (TFPI2,
also known as placental protein 5). OVGP1 and PAPPA
were significantly upregulated by all 3 FTSEC cultures fol-
lowing the transition to 3D (P > 0.05, Figure 6a). TFPI2
was also significantly upregulated in 2/3 3D cultures (P >y profiling of 2D and 3D cultured FTSECs. The most significantly
D cultures of FTSEC03, as well as in two additional cell lines from
ltured cells (a) MARCH4 and (b) DIAPH3 were significantly
nd was observed for GINS4 although this did not reach statistical
2A and (f) LRRK2 were all upregulated in all 3 samples following a
o-tailed paired Student’s T-tests were used to compare 2D and 3D
Table 3 Analysis of gene ontology terms over-represented in 3D cultured cells
GO terms over-represented in genes down-regulated in 3D cultured cells
Term Exp count Count Size Adjusted P-value
Organelle fission 11.106 61 321 2.00E-25
Cell division 8.987 50 266 7.74E-21
Mitotic prometaphase 2.872 30 83 2.50E-20
Cell cycle process 10.267 44 347 7.74E-14
Cell cycle checkpoint 2.962 23 87 3.72E-12
Interphase 11.522 41 333 4.02E-10
Chromosome segregation 2.835 20 84 1.14E-09
Regulation of cell cycle process 8.241 33 245 2.28E-09
Cellular component organization or biogenesis 104.766 163 3028 9.59E-09
Cellular component organization at cellular level 73.542 125 2225 1.97E-08
DNA replication 5.364 25 157 2.37E-08
DNA strand elongation involved in DNA replication 1.073 12 31 3.95E-08
Mitotic cell cycle 5.122 24 175 4.65E-08
Negative regulation of cell cycle 11.162 35 326 2.89E-07
DNA metabolic process 4.759 21 159 1.64E-06
Microtubule anchoring 0.830 9 24 8.20E-06
Chromosome organization 15.877 39 475 2.38E-05
Cellular response to stress 29.513 59 853 2.38E-05
Mitosis 4.269 18 137 3.02E-05
Regulation of microtubule-based process 2.284 13 66 3.94E-05
Telomere maintenance via recombination 0.796 8 23 6.95E-05
DNA recombination 3.716 16 111 8.96E-05
Telomere maintenance via semi-conservative replication 0.830 8 24 9.23E-05
Double-strand break repair via homologous recombination 1.419 10 41 9.61E-05
DNA repair 6.807 22 206 1.17E-04
Mitotic spindle organization 0.865 8 25 1.17E-04
Microtubule-based process 4.335 17 132 1.28E-04
Chromosome localization 0.657 7 19 1.74E-04
Regulation of transcription involved in G1/S phase of mitotic cell cycle 0.692 7 20 2.50E-04
CenH3-containing nucleosome assembly at centromere 0.727 7 21 3.41E-04
DNA replication-independent nucleosome organization 0.727 7 21 3.41E-04
DNA packaging 2.857 13 84 3.56E-04
S phase of mitotic cell cycle 4.325 16 125 4.55E-04
Nucleotide-excision repair, DNA gap filling 0.623 6 18 0.002
ATP-dependent chromatin remodeling 0.934 7 27 0.002
Nucleosome assembly 2.491 11 72 0.002
Microtubule-based movement 3.460 13 100 0.003
G1/S transition of mitotic cell cycle 4.693 15 138 0.004
Anaphase-promoting complex-dependent proteasomal ubiquitin-dependent
protein catabolic process
2.733 11 79 0.005
Transcription-coupled nucleotide-excision repair 1.488 8 43 0.006
Mitotic sister chromatid segregation 0.510 5 15 0.006
Establishment of organelle localization 2.371 10 69 0.007
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Table 3 Analysis of gene ontology terms over-represented in 3D cultured cells (Continued)
Cellular component assembly 34.876 57 1008 0.007
Positive regulation of cell cycle cytokinesis 0.311 4 9 0.009
Mitotic metaphase 0.138 3 4 0.009
Spindle organization 0.605 5 18 0.013
Mitochondrial translation 0.346 4 10 0.013
DNA-dependent DNA replication initiation 0.934 6 27 0.013
G2/M transition DNA damage checkpoint 0.934 6 27 0.013
Maintenance of protein location 2.630 10 76 0.013
G2/M transition of mitotic cell cycle 3.646 12 106 0.013
Phosphatidylinositol-mediated signaling 2.180 9 63 0.014
Maintenance of location in cell 2.664 10 77 0.014
Spliceosomal snRNP assembly 0.969 6 28 0.015
Meiotic cell cycle 3.737 12 108 0.015
Microtubule depolymerization 0.657 5 19 0.016
Telomere organization 1.799 8 52 0.016
Mitotic chromosome condensation 0.381 4 11 0.016
Regulation of attachment of spindle microtubules to kinetochore 0.173 3 5 0.016
Spindle assembly 1.001 6 29 0.016
RNA splicing, via transesterification reactions 6.747 17 195 0.017
Cytoskeleton organization 12.037 25 356 0.017
Macromolecular complex subunit organization 3.893 12 119 0.020
Negative regulation of organelle organization 4.048 12 117 0.028
Attachment of spindle microtubules to kinetochore 0.205 3 6 0.028
Mitotic metaphase plate congression 0.450 4 13 0.029
Response to ionizing radiation 3.010 10 87 0.030
Regulation of cyclin-dependent protein kinase activity 2.526 9 73 0.032
Regulation of mitosis 1.165 6 34 0.033
RNA processing 20.137 35 582 0.034
Metaphase plate congression 0.069 2 2 0.039
Aspartate biosynthetic process 0.069 2 2 0.039
Glutamate catabolic process to aspartate 0.069 2 2 0.039
Glutamate catabolic process to 2-oxoglutarate 0.069 2 2 0.039
Regulation of hippo signaling cascade 0.069 2 2 0.039
Negative regulation of mitotic recombination 0.069 2 2 0.039
Deoxyribonucleotide biosynthetic process 0.242 3 7 0.040
Kinetochore assembly 0.242 3 7 0.040
Protein K6-linked ubiquitination 0.242 3 7 0.040
M phase of mitotic cell cycle 0.239 3 8 0.041
GO terms over-represented in genes upregulated in 3D cultured cells
Term Exp count Count Size Adjusted P-value
Positive regulation of transcription from RNA polymerase II promoter 9.063 26 362 0.003
80 terms were over-represented in the genes that were underexpressed in 3D and 1 GO term was significantly over-represented in genes upregulated when
FTSECs were transitioned to a 3D microenvironment. The majority of these terms were associated with cell cycle progression, mitosis and DNA replication.
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Figure 6 FTSEC biomarker expression in 2D and 3D and cluster analysis comparing genome-wide transcriptomic profiles of 2D and 3D
cultured FTSECs to follicular and luteal phase fallopian tube epithelium. (a) Expression of FTSEC biomarkers is typically higher in 3D than in
2D (i) oviductal glycoprotein 1, (ii) pregnanacy-associated plasma protein A and (iii) tissue factor pathway inhibitor 2. (b) Euclidean Pearson
clustering analyses reveal that 2D cultured FTSECs cluster with follicular phase fallopian tube epithelium, whereas 3D cultured fallopian tube
epithelial cells cluster with luteal phase tubal epithelium. Each point on the graph indicates an individual microarray profile, technical replicates of
cultured cells are shown by colored circles, open circles denoting 2D cultured cells and closed circles denoting 3D cultured FTSECs. Black open
circles indicate follicular phase fallopian tube epithelial samples, closed circles indicate luteal phase fallopian tube epithelium. Each point
represents an individual patient. All patients from Georges et al. and Tone et al. [17,18] datasets are shown.
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2D and 3D FTSEC cultures with profiles of fresh human
fallopian tube tissue specimens. Datasets representing fal-
lopian tube epithelial tissues harvested at different points
of the menstrual cycle were selected (Tone et al. and
George et al. [17,18]). We used cluster analysis to examine
the similarities between global transcriptomic profiles of
2D cultured FTSECs, 3D cultured FTSECs, luteal phase
fallopian tube epithelial cells and follicular phase fallopian
tube epithelial cells. Regardless of the clustering method
used (maximum or Euclidean distance, calculated from ei-
ther the Pearson or Spearman correlation coefficients),
profiles from 2D cultures clustered with fallopian tube
epithelial tissues collected during the follicular phase of
the menstrual cycle, whilst 3D-cultured cells consistently
clustered with luteal phase fallopian tube epithelium
(Figure 6b and Additional file 3: Figure S2).
Discussion
Here, we describe a novel approach to model normal
primary fallopian tube secretory epithelial cells (FTSECs)
in an in vitro three-dimensional (3D) spheroid system.Culturing FTSECs as spheroids restores the 3D architec-
ture of the tissue in vivo, as well as gradients of nutri-
ents, oxygen, carbon dioxide and other macromolecules.
We observed molecular and cellular features of FTSECs
cultured in 3D more closely resembled fresh FTSEC tis-
sue samples than monolayer cultured fallopian tube
secretory epithelial cells. One striking change associated
with the transition to 3D was the reduced proliferation
rate of cells in 3D compared to 2D, as demonstrated by
MIB1 and p53 staining. Cells in 3D were less prolifera-
tive which was also reflected in the changing patterns of
gene expression following transition from 2D to 3D.
This is consistent with a previous study of normal ovar-
ian surface epithelial cells cultured in 3D cultures [14],
and is also true for normal breast cells [19]. Since pro-
liferation of the fallopian tube mucosa occurs in pre-
malignant or malignant lesions [20], these data suggest
that these 3D models more closely reflect the quiescent
status of normal FTSECs in vivo and are more biologic-
ally relevant models of normal FTSECs than 2D mono-
layers for studying normal fallopian tube biology and
tumorigenesis. Furthermore, 3D culturing enhanced the
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specific glycoprotein 1 (OVGP1), also known as mucin 9,
is normally secreted by non-cilated tubal epithelia and im-
proves in vitro fertilization rates by reducing polyspermy
and increasing blastocyst formation rates [21,22]. We
found OVGP1 to be upregulated ~2-4 fold in FTSECs cul-
tured in 3D. Similarly, a second glycoprotein, pregnancy
associated plasma protein A (PAPPA) was also signifi-
cantly upregulated in 3D. Increased expression of these
bioactive glycoprotein molecules suggests FTSECs grown
in 3D have enhanced functional differentiation compared
to their 2D counterparts.
We compared global expression profiles of 2D and 3D
cultured cells with biomarker expression in primary
fresh fallopian tube tissue samples. We showed that gene
profiles in 2D cultured cells cluster with follicular phase
fallopian epithelial tissue, whereas 3D cultured cells clus-
ter with luteal phase fallopian tube samples. This result
may also be driven by the proliferative signature of the
2D cultured cells, as the follicular phase of the men-
strual cycle is the proliferative phase, when raised levels
of estradiol stimulate proliferation of the epithelia lining
the endometrium and fallopian tube [23]. We found that
gene expression profiles of 3D cultured FTSECs cluster
with those of luteal phase fallopian tube tissues. This
phase of the cell cycle is the secretory phase, which may
indicate a commitment to secretory differentiation
FTSECs cultured in 3D. Consistent with this, we ob-
served upregulation of an secreted proteins as well as an
FTSEC marker (PAX8) when one FTSEC line was cul-
tured in 3D. These data strongly suggest that culturing
in 3D enhances functional differentiation of FTSECs to
a secretory phenotype.
Previous studies have reported culture of human fallo-
pian tube epithelia ex vivo, on collagen gel and alginate
matrices [4,5]. These models have significantly advanced
our ability to model human and murine polarized fallo-
pian tube epithelia in vitro. However, one limitation of
ex vivo models is the restricted ability to sub-culture the
cells. Using a growth factor rich media we were able to
subculture the fallopian tube epithelial cells we isolated.
We then selected a spheroid culture method to establish
3D cultures because this approach offers flexibility for
downstream molecular analysis, and can be scaled up or
down to perform high-throughput molecular screening
or large-scale mass cultures. Although we did not supply
matrix proteins in the cultures, fallopian tube secretory
epithelial cells produced a matrix of which laminin was
a major component. Laminin is the major protein in the
basal lamina, the aspect of the basement membrane to
which epithelial cells are adhered in vivo via integrin-
mediated interactions. We hypothesize that altered cell-
matrix interactions may contribute to the altered gene
expression patterns we observed. While the 3D FTSECcultures presented here do not recreate the complex
convoluted architecture of the lumen of a fallopian tube
in vivo, in FTSEC spheroids the epithelial cell-basement
membrane interaction is restored. We observed that the
outer surface of the spheroid is reminiscent of the lumen
of the fallopian tube in that cells are in contact with
other mucosal epithelia throughout the lateral domains
of the cell, and basal domains of the cells are in contact
with a basement membrane-type matrix. In contrast,
cells trapped within the spheroid cores are surrounded
by matrix, which is an ectopic microenvironment for
normal epithelial cells. We hypothesize that this may
induce programmed cell death, resulting in the high fre-
quency of apoptotic cell debris observed within the cores
but not at the periphery of FTSEC spheroids. Alterna-
tively the physiological conditions within spheroids
could have contributed to the changes survival of cells at
the centre of the multicellular aggregates, since mathem-
atical modeling suggests that deficiencies in ATP [24],
glucose, hydrogen and oxygen [25] may all induce nec-
rotic cell death of cells within spheroid cores.
Many key cellular processes are now known to be dif-
ferently regulated between 2D and 3D cultures, and vari-
ous factors can induce differential gene expression in
3D, including altered cell-cell and/or cell-matrix commu-
nications, nutrient and oxygen gradients, and reduced
rates of proliferation. We propose that the 3D models are
more biologically relevant tools of FTSECs than trad-
itional 2D monolayers with which to study fallopian tube
epithelial cell biology and pathogenesis. Perhaps the
greatest potential for clinical impact of these models will
come from their use in studies of tumor initiation. This
has become particularly significant since it was established
recently that the epithelia lining of the fallopian tube likely
represents the cell of origin for a proportion of HGSOCs.
HGSOCs bear morphological resemblance to Müllerian
epithelia and over 80% of this tumor type overexpress
PAX8 [26], an FTSEC marker that can be used to distin-
guish ovarian serous tumors from other, morphologically
similar neoplasms [27,28]. We identified additional FTSEC
biomarkers that represent novel candidate HGSOC bio-
markers. These include LRRK2, a gene that encodes a kin-
ase involved in Parkinsons Disease [29,30]. LRRK2 has not
previously been implicated in ovarian cancer development
but analyses of The Cancer Genome Atlas (TCGA) data
suggests ~3% of primary HGSOCs harbor somatic muta-
tions in this gene [31-33]. Other novel FTSEC biomarkers
that are overexpressed in HGSOCs include CELSR3, an
atypical cadherin; ABCC3, an ABC transport protein im-
plicated in drug resistance [34]; and CTHRC1, a secreted
protein shown to be a candidate biomarker for breast
and pancreatic cancer [35,36]. Analyses of primary
HGSOC specimens and sera collected from ovarian can-
cer patients will be required to determine whether any
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early detection of HGSOC.
While it is now widely accepted that a proportion of
HGSOCS originate in the fallopian tube, the early stages
of disease development are poorly understood and many
questions remain to be answered. Reports show differ-
ences in the proportions of ciliated and secretory
epithelial cells, marker expression and hormone respon-
siveness between the epithelia found in fimbrial and
ampullary regions of the fallopian tube [23,37,38]. How-
ever, as yet we do not yet know why FTSECs in the fim-
brial region of the fallopian tube are more prone to
neoplastic transformation. One hypothesis is that the
proximity to the mitogenic environment of the ovarian
stroma may influence the phenotype of fimbrial FTSECs.
Alternatively the region of transition between FTSECs and
ovarian mesothelial-type epithelial cells is inherently more
prone to neoplastic transformation. In the future, these
3D models of FTSEC transformation that incorporate
common somatic genetic alterations characteristic of
HGSOC (BRCA1, p53 [31]) or even recently discovered
susceptibility alleles that confer low-risk of EOC in the
general population [39-45] will be vital tools in answering
some of the key questions regarding EOC initiation and
development.
Conclusion
In conclusion we have developed a novel 3D in vitro
culture model of fallopian tube secretory cells that rep-
resent a precursor tissue of high-grade serous ovarian
cancer. The greatest potential clinical use for these
models is likely to come from molecular and phenotypic
studies of the initiation and early stage development of
ovarian cancer leading to the discovery of novel bio-
markers for early stage disease detection. These models
may also have applications beyond the study of ovarian
carcinogenesis, for example for studying the interactions
between the fallopian tube epithelium and oocytes or zy-
gotes. Co-culture of fallopian tube epithelial cells has
been shown to promote the in vitro development of em-
bryos. In future, novel 3D co-culture methodologies, in
which glycoprotein secretion is enhanced, may improve
in vitro embryogenesis. Models of benign fallopian tube
diseases that are commonly associated with female infer-
tility, such as salpingitis and pelvic inflammatory disease,
are also few in number; but the models we describe here
could be used to mimic such conditions in vitro and
help to improve their diagnosis and treatment. Ultim-
ately, it is hoped that these models will lead to much
needed insights into the biology and pathogenesis of fal-
lopian secretory epithelial cells and that this knowledge
with be invaluable in increasing our ability to diagnose
and treat benign and malignant disease arising in the fal-
lopian tubes.Methods
Tissue collection and cell culture
Patients scheduled to undergo surgical procedures for
benign gynecological conditions (including fibroids,
polyps) or total abdominal hysterectomies for endomet-
rial cancer provided informed written consent, prior to
surgery, agreeing to participate in the study. This study
was performed with permission of the UCL Institutional
Ethics Committee. Fallopian tubes were inspected by
the operating surgeon and a gynecological pathologist
and confirmed to be free of malignancy. The distal ampul-
lary region of the fallopian tube was isolated and dissected
open to reveal the lumen. Epithelial cells were harvested
by gentle brushing with a sterile cytobrush. All FTSEC cell
cultures were maintained in MCDB105:Medium 199
(mixed in a 1:1 ratio) supplemented with 15% fetal bovine
serum (Hyclone), 10 ng/ml epidermal growth factor,
0.5 mg/ml hydrocortisone, 5 mg/ml insulin, and 34 mg
protein/ml bovine pituitary extract, (all Sigma, St Louis,
MO, USA). For growth curves 1 × 105 cells were plated in
triplicate. Cultures were passaged and population dou-
blings (PD) calculated using the following formula:
PD = log (total cell number at each passage/initial cell
number)/log2.
For analysis of cellular karyotype, cells were taken at a
low passage and seeded at low density in a 25 cm2 flask.
The karyotypes were analysed by a certified clinical cyto-
geneticist (TDL genetics, London, UK). The number of
chromosomes as well as their length, the position of the
centromeres, banding pattern and any other physical
characteristics were commented on to give a detailed de-
scription of any abnormalities.Immunofluorescent cytochemistry
Cell monolayers were grown on glass coverslips to of
~80% confluency. Cells were washed with ice cold PBS-Ag
(PBS with 0.3% fish skin gelatin, Sigma) and fixed for
10 min in 3% paraformaldehyde, then re-washed with PBS-
Ag. Cells were permeabilized with 0.3%v/v Triton X-100 in
PBS-Ag, rinsed twice again and blocked with goat serum
(Invitrogen, Carlsbad, CA, USA) for 30 min. Primary anti-
bodies were diluted 1:1000 in PBSAg and applied to the
cells for 1 hour. After rinsing the antibody, secondary was
applied for 20 min in the dark, Alexa Fluor 488-coupled
secondary or antibodies (Invitrogen) were used for antigen
detection. The coverslips were then rinsed and transferred
to labelled slides to add DAPI stain for nuclear staining.
The slides were viewed under an Olympus BX64 fluores-
cence microscope (Olympus, Tokyo, Japan) and images
were captured and analyzed using Cytovision Genus 3.6
Software (Leica, Wetzlar, Germany).
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Tissue culture vessels were twice coated with a 1.5% of
poly-2-hydroxyethyl methacrylate (polyHEMA, Sigma) so-
lution in 95% ethanol, and allowed to dry. Before use,
polyHEMA coated plates were washed with sterile PBS.
Cells were trypsinised and counted, and 1×105 cells plated
into polyHEMA coated P100 dishes in 25 mls complete
medium. To fix the 3D cultures, spheroids were collected
into a 50 ml falcon tube washed twce in PBS and fixed for
30 mins in neutal-buffered formalin (VWR, West Chester,
PA, USA). Fixed 3D cultures were then processed into par-
affin blocks, sectioned and stained by immunohistochemis-
try at UCL Advanced Diagnostics immunocytochemistry
service laboratory (UCL, London) and at the Translational
Pathology Core Facility at UCLA, Los Angeles, California.
Staining was performed using standard immunohistochem-
ical staining techniques with the following antibodies colla-
gen type I (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), collagen type 4 (Abcam, Cambridge, MA, USA),
laminin (Dako, Glostrup, Denmark), pan-cytokeratin (clone
AE1/AE3, Dako), p53 (Do7, Dako) and MIB1 (Dako).
Transmission electron microscopy
FTSECs were grown as 3D spheroids for 4 days, after
which cells were harvested by centrifugation and the cul-
ture media aspirated. Spheroids were washed with PBS
and fixed with ½ strength Karnovsky’s Fixative overnight
at 4°C. Spheroids were then rinsed in 0.1 M Cacodylate
Buffer for 10mins, post-fixed in 2% Osmium Tetroxide for
1 hour, then rinsed again in 0.1 M Cacodylate Buffer for
10 mins. Blocking was performed by immersing spheroids
in 1% Uranyl Acetate for 1 hour; spheroids were washed
with distilled water and by dehydrated with 50%, 70%,
85%, 95% ethanol for 10 mins each, the 100% ethanol
three times for 10 mins each. Spheroids were immersed
1× in 50:50 Ethanol:Propylene Oxide and 3× in Propylene
Oxide for 10 mins each. Spheroids were then transferred
to 50:50 Epon:Propylene Oxide for 3 hrs, then placed in a
vacuum for 1 hr. The previous step was repeated with
80:20 Epon:Propylene Oxide mix then pure Epon (twice)
for 3 hrs and in vacuum for 1 hr. Blocks were finally trans-
ferred to a 60°C oven overnight. Blocks were sectioned for
Transmission Electron Microscopy and analysed using a
JEOL JEM 2100 200 Kv Transmission Electron Micro-
scope (JEOL, Peabody, MA).
Gene expression microarray analysis
RNA was extracted from 2D or 4-day old 3D cultures
using the Illustra RNAspin mini kit (GE Heathcare) and
microarray analyses performed using the Illumina HT-
12 Gene Expression Beadchips (Illumina, San Diego,
CA, USA) at the USC Epigenome Centre core facility.
Data have been deposited onto the GEO database. Raw
data were analysed using methods from the specifiedBioconductor [46] packages; beadarray to import and
process the raw data from the chip images [47], the BASH
algorithm [48] for detecting and managing spatial artefacts;
the package limma [49], to implement background correc-
tion using negative control probes and quantile signal
normalisation using negative and positive control probes
[50]. Summary data was exported as log transformed mean
values of probe signals. For differential gene expression
analysis the log-transformed summary probe expression
data were analysed using an implementation of the
Signifcance Analysis of Microarrays (SAM) method [51] in
the package siggenes. A two-class analysis using a modifed
t-statistic was used to identify genes that were differentially
expressed according to their culture conditions.
Gene ontology analysis
The R package GOstats was used to identify gene
ontology terms that are over/under represented in the
differentially expressed genes. An implementation of the
Hypergeometric test [52] was performed using the func-
tion hyperGTest. This computes Hypergeometric p-
values for over or under-representation of each GO term
in the specified ontology among the GO annotations for
genes of interest. P-values were corrected for multiple
testing of the total number of ontology terms, using the
method described by Benjamini & Hochberg [53].
Cluster analysis
Gene expression data for human fallopian tube epithelial
cells were downloaded from the Gene Expression Omni-
bus (http://www.ncbi.nlm.nih.gov/geo/). The data of Tone
et al. and George et al. [17,18] and were downloaded as
raw files from GEO (GSE28044 and GSE12172). These
data are profiles for microdissected fallopian tube epithe-
lial cells thus minimizing the chance that contamination
by stromal or immune cells could affect the profiles. Un-
supervised hierarchical cluster analyses were performed to
ascertain the quality of biological replicates and also how
the relationships between cell lines and culture conditions
impact upon gene expression, as well the similarities
between culture conditions and primary tissue samples.
Maximum and Euclidean distances were calculated,
again in ‘R’, using Spearman’s or Pearson’s correlation
on untransformed probe expression values and clus-
tered by Ward’s minimum variance method. The data
set supporting the results of this article is available in
the GEO repository (www.ncbi.nlm.nih.gov/geo/), study
identifier GSE51220.
Additional files
Additional file 1: Table S1. Gene expression microarray analysis of
gene expression changes associated with transfer of fallopian tube
secretory epithelial cells (FTSECs) from a 2D to a 3D microenvironment.
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compared to 2D cultured FTSECs. 53 genes were significantly
upregulated, 47 genes were significantly downregulated.
Additional file 2: Figure S1. Validation of genes identified as
differentially expressed in 2D and 3D cultured FTSECs. We validated the
top 3 up- and downregulated genes by qPCR.
Additional file 3: Figure S2. Cluster analyses comparing genome-wide
transcriptomic profiles of 2D and 3D cultured FTSECs to follicular and
luteal phase fallopian tube epithelium. Each point on the graph indicates
an individual microarray profile, technical replicates of cultured cells are
shown by colored circles, open circles denoting 2D cultured cells and
closed circles denoting 3D cultured FTSECs. Black open circles indicate
follicular phase fallopian tube epithelial samples, closed circles indicate
luteal phase fallopian tube epithelium. Each point represents an
individual patient. All patients from Georges et al. and Tone et al. [17,18]
datasets are shown. Clustering is consistent regardless of cluster method
used (a) Euclidean Spearman, (b) maximum Pearson and (c) maximum
Spearman.
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